A study from Yale University explores a condition termed "post-vaccination syndrome" (PVS), which appears to associate prolonged symptoms following COVID-19 vaccination. Published as a preprint, the research has not yet undergone peer review.
• Symptoms Identified: The study outlines several symptoms linked to PVS, including fatigue, brain fog, muscle aches, sleep issues, anxiety, and nerve damage.
• Study Participants: Researchers examined 42 individuals diagnosed with PVS, comparing their health indicators to a control group.
• Spike Protein Findings: A notable finding was that participants who had been vaccinated 600 to 700 days prior had higher levels of spike protein than those vaccinated more recently, although the study measured protein levels only once.
• Need for More Research: The study emphasizes that further research is needed to establish definitive causes for PVS, as multiple biological markers were explored.
• Comparison to Long COVID: PVS shares symptoms with long COVID but differs in that those with PVS had lower antibody levels against the spike protein compared to the control group.
• Healthcare Acknowledgment: The study points out that PVS is often neglected in medical discussions and deemed a "radioactive" topic by health authorities, leading to hesitance in funding and publishing related research.
• Public Health Implications: It is noted that while the study reveals adverse effects, the benefits of COVID-19 vaccines, which have saved lives, are also acknowledged.
The Yale study sheds light on post-vaccination syndrome and highlights the need for further investigation. The findings may guide improvements in vaccine safety and inform public health strategies, especially with changing leadership in health services.
No comments:
Post a Comment